Edges in Network
| Network | GSE12093_top8000 - GSE12093 - SiGN-BN NNSR |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | ENO1 |
| Upstream (Parents) |
|---|
| (<<) ACTB → ENO1 |
| (<<) TMED2 → ENO1 |
| (<<) ARF1 → ENO1 |
| Downstream (Children) |
|---|
| ENO1 → ZFYVE21 (>>) |
| ENO1 → MAT2A (>>) |
| ENO1 → ACTB (>>) |
| ENO1 → HAUS7///TREX2 (>>) |
| ENO1 → ASMT (>>) |
| ENO1 → ERBB2 (>>) |
| ENO1 → RIOK3 (>>) |
| ENO1 → CD164 (>>) |
| ENO1 → SLC6A20 (>>) |
| ENO1 → FLOT1 (>>) |
| ENO1 → DDX3X (>>) |
| ENO1 → IL13RA1 (>>) |
| ENO1 → KPNA4 (>>) |
| ENO1 → ATP6V1A (>>) |
| ENO1 → ADRB3 (>>) |
| ENO1 → FCGR3B///FCGR3A (>>) |
| ENO1 → CNN3 (>>) |
| ENO1 → CD24 (>>) |
| ENO1 → MAZ (>>) |
| ENO1 → STIP1 (>>) |
| ENO1 → MCL1 (>>) |
| ENO1 → C1orf144 (>>) |
| ENO1 → RRAS2 (>>) |
| ENO1 → GAPDH (>>) |
| ENO1 → VEGFA (>>) |
| ENO1 → MARK4 (>>) |
| ENO1 → GM2A (>>) |
| ENO1 → EFNB1 (>>) |
